Navigation Links
What parasites eat is the key to better drug design

A team led by Professor Malcolm McConville from the Bio21 Institute, University of Melbourne developed a new analytical method which can be used for many infectious parasites and bacteria. The technique has revealed which metabolic pathways are essential for the parasite's survival, down to the particular atoms it uses as a food source.

"This a very significant breakthrough in this field because the more we know about these dangerous pathogens and how they live, the better we can fight them with new, effective drugs," said Professor McConville.

"Current anti-parasitic drugs have enormous side effects as they don't target specific pathogen metabolic pathways. We now have a greater understanding of Leishmania and can develop specific drugs with minimal side effects."

The team studied the parasite's metabolism by labelling carbon atoms in its food source (the sugar glucose) and using cutting edge equipment including nuclear magnetic resonance (NMR) to follow how the atoms were used in the parasite's metabolism. The results reveal which of the metabolic pathways are essential to Leishmania's survival, and therefore good drug targets to block and kill the parasite.

The parasite Leishmania was used to develop the technique as its complex life cycle and ability to infect many animals makes treatment very difficult and limits the effectiveness of a vaccine .

Leishmania causes a range of infections in humans, from skin conditions to organ infection which can be fatal. The parasite lives within tiny sandflies which bite an animal or human to get the blood they require to produce eggs, thereby passing on the Leishmania parasite.

The new study is published in the current issue of the international Journal of Biological Chemistry.


Contact: Sally Sherwen
University of Melbourne

Page: 1

Related biology news :

1. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
2. Locking parasites in host cell could be new way to fight malaria
3. Immune genes adapt to parasites
4. Study finds role for parasites in evolution of sex
5. Discovery to aid in future treatments of third-world parasites
6. Parasites ready to jump
7. Penn researchers identify immune cells that fight parasites may promote allergies and asthma
8. Immune evasion common in many viruses, bacteria and parasites is uncommon in M. tuberculosis
9. Discovery offers hope of saving sub-Saharan crops from devastating parasites
10. MIT researchers study the danger of toxoplasma parasites
11. Comparison of genomes of plant parasites provides solid clues for response
Post Your Comments:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: